Soliton Stock Tries Bottoming Ahead of Key Industry Event

Soliton Stock While the general stock market sold off in September, medical device company Soliton (SOLY) finally came alive. So far, the momentum continues into this month with Soliton’s stock closing at a 2 1/2 month high. SOLY is forming a potential bottom with a higher low and two higher highs including a breakout above … Read more

A Stock Market On Edge – Above the 40 (June 26, 2020)

Stock Market Statistics AT40 = 40.1% of stocks are trading above their respective 40-day moving averages (DMAs) (2-month low)AT200 = 20.1% of stocks are trading above their respective 200DMAs VIX = 34.7Short-term Trading Call: neutral Stock Market Commentary After a one-day respite, the damage in the stock market continued. This time, the damage was more … Read more

Soliton: How to Trade A Secondary Stock Offering

Last week, I anticipated that Soliton would announce a secondary offering of stock following the release of a successful trial of its cellulite treatment. Soliton (SOLY) delivered with after hours news of a secondary stock offering in the form of an SEC filing. So now what? The Trade Rules At the time of writing, traders … Read more

Soliton: What Awaits the Stock After News on Cellulite Trial

“The Company’s cash, cash equivalents and restricted cash on hand is sufficient to fund the Company’s operations into December 2020 but not beyond.” This quote from the May 14 earnings report from Soliton (SOLY) is tattooed in my mind as I consider the implications of the company’s recent good news on cellulite treatment. On June … Read more

Green Shoots for A Grinding and Historic Oversold Period – Above the 40 (March 20, 2020)

AT40 = 2.0% of stocks are trading above their respective 40-day moving averages (DMAs) (18th oversold day)AT200 = 2.6% of stocks are trading above their respective 200DMAs (new low for the oversold period)VIX = 66.0Short-term Trading Call: bullish Stock Market Commentary The bear market grinds on. At the time of writing, U.S. stock market futures … Read more